does tirzepatide mess up your period The Potential Utility of for the Management of Polycystic Ovary Syndrome Do GLP-1 weight loss drugs

With our platform, you have 24/7 access to a dedicated team of specialists

In a pool of two ZEPBOUND clinical trials for weight reduction (Studies 1 and 2), cholelithiasis was reported in 1.1% of ZEPBOUND-treated patients and 1% of placebo-treated patients, cholecystitis was reported in 0.7% of ZEPBOUND-treated patients and 0.2% of placebo-treated patients, and cholecystectomy was reported in 0.2% of ZEPBOUND-treated patients and no placebo-treated patients

The registration identifier on clinicaltrials.gov is NCT04847557

Adjusting the tirzepatide dose, optimizing nutritional intake, or addressing concurrent medical conditions may be necessary